PMC:7243778 / 20674-20980 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"500","span":{"begin":61,"end":69},"obj":"Species"},{"id":"501","span":{"begin":193,"end":201},"obj":"Species"},{"id":"502","span":{"begin":6,"end":11},"obj":"Species"},{"id":"503","span":{"begin":287,"end":300},"obj":"Disease"}],"attributes":[{"id":"A500","pred":"tao:has_database_id","subj":"500","obj":"Tax:1335626"},{"id":"A501","pred":"tao:has_database_id","subj":"501","obj":"Tax:1335626"},{"id":"A502","pred":"tao:has_database_id","subj":"502","obj":"Tax:9606"},{"id":"A503","pred":"tao:has_database_id","subj":"503","obj":"MESH:D018352"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Three human monoclonal Abs, m336, m337, and m338 bind RBD of MERS-CoV at extremely low concentration, 4.2, 9.3, and 15 nM, respectively. m336, that neutralized 50% of both pseudotyped and live MERS-CoV at 0.005 and 0.07 μg/mL, respectively, suggested the prophylaxis and therapy of MERS-CoV infection [70]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T70","span":{"begin":291,"end":300},"obj":"Disease"}],"attributes":[{"id":"A70","pred":"mondo_id","subj":"T70","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Three human monoclonal Abs, m336, m337, and m338 bind RBD of MERS-CoV at extremely low concentration, 4.2, 9.3, and 15 nM, respectively. m336, that neutralized 50% of both pseudotyped and live MERS-CoV at 0.005 and 0.07 μg/mL, respectively, suggested the prophylaxis and therapy of MERS-CoV infection [70]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T266","span":{"begin":6,"end":11},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T267","span":{"begin":73,"end":82},"obj":"http://www.ebi.ac.uk/efo/EFO_0000876"}],"text":"Three human monoclonal Abs, m336, m337, and m338 bind RBD of MERS-CoV at extremely low concentration, 4.2, 9.3, and 15 nM, respectively. m336, that neutralized 50% of both pseudotyped and live MERS-CoV at 0.005 and 0.07 μg/mL, respectively, suggested the prophylaxis and therapy of MERS-CoV infection [70]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T163","span":{"begin":0,"end":306},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Three human monoclonal Abs, m336, m337, and m338 bind RBD of MERS-CoV at extremely low concentration, 4.2, 9.3, and 15 nM, respectively. m336, that neutralized 50% of both pseudotyped and live MERS-CoV at 0.005 and 0.07 μg/mL, respectively, suggested the prophylaxis and therapy of MERS-CoV infection [70]."}

{"project":"2_test","denotations":[{"id":"32450171-24789777-66454496","span":{"begin":302,"end":304},"obj":"24789777"}],"text":"Three human monoclonal Abs, m336, m337, and m338 bind RBD of MERS-CoV at extremely low concentration, 4.2, 9.3, and 15 nM, respectively. m336, that neutralized 50% of both pseudotyped and live MERS-CoV at 0.005 and 0.07 μg/mL, respectively, suggested the prophylaxis and therapy of MERS-CoV infection [70]."}